The most trusted news from Asia and the Pacific

Provided by AGP

News Channel Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Channel Asia.

Press releases published on May 6, 2026

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
NexGold Intersects 14.10 g/t Gold Over 6.0 Metres, 2.99 g/t Gold over 20.0 Metres and 10.67 g/t Gold Over 7.0 Metres at the Goldlund Deposit, Ontario
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
Intchains Group Limited Announces Transition to Semi-Annual Financial Reporting
GDS to Report First Quarter 2026 Financial Results Before the Open of the U.S. Market on May 20, 2026
Recursion Reports First Quarter Financial Results and Provides Business Update
Geely Riddara at Auto China 2026: Redefining the Global New Energy Pickup Landscape with Product Excellence
Newcore Gold Drilling Intersects 1.23 g/t Gold over 33.0 Metres, Including 2.16 g/t Gold over 13.0 Metres, at the Enchi Gold Project, Ghana
UCLOUDLINK GROUP INC. to Report First Quarter 2026 Financial Results on May 13, 2026
Starcoin Ecosystem Prepares to Launch RWA Launchpad Using ERC-3643 Standard for Secure RWA Tokenization
PONY AI Inc. to Report First Quarter 2026 Financial Results on May 26, 2026
RedotPay Launches AI-powered Agentic Payments Using Stablecoins on Tempo’s Machine Payments Protocol (MPP)
Toobit Confirms 100%+ Asset Backing in Latest Hacken Proof of Reserves Report
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary
LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis

Share us

on your social networks:

Sign up for:

News Channel Asia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.